Streetbeat News

Analyst Ratings

OHI

Wells Fargo analyst Connor Siversky has downgraded Omega Healthcare Invts (NYSE:OHI) from Overweight to Equal-Weight and set a price target of $32.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:57 am

DY

B. Riley Securities has downgraded Dycom Industries (NYSE:DY) from Buy to Neutral and lowered the price target from $134 to $111.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:56 am

ZWS

Baird analyst Michael Halloran maintains a Neutral rating on Zurn Elkay Water (NYSE:ZWS) and raises the price target from $23 to $30.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 9:55 am

RTX

Morgan Stanley analyst Kristine Liwag has downgraded RTX (NYSE:RTX) from Overweight to Equal-Weight and lowered the price target from $110 to $95.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:53 am

SNAP

Snap, Inc. (NYSE:SNAP) shares fell over 19% in premarket trading due to lackluster guidance, despite better than feared Q2 results. Engagement metrics improved, with daily active users in North America increasing for the first time since Q3 2022. However, Snap faces competition in Augmented Reality from larger companies and struggles to win back advertiser budgets.

Portfolio Pulse from Shanthi Rexaline

July 26, 2023 | 9:53 am

NTAP

Morgan Stanley analyst Meta Marshall has upgraded NetApp (NASDAQ:NTAP) from Underweight to Equal-Weight and raised the price target from $60 to $74.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:52 am

BMTX

Chardan Capital analyst Brian Dobson has maintained a 'Buy' rating on BM Technologies (AMEX:BMTX), but lowered the price target from $13 to $8.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:50 am

ATRC

Needham analyst Mike Matson maintains a 'Buy' rating on AtriCure (NASDAQ:ATRC) and raises the price target from $60 to $68.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:49 am

MMSI

Needham analyst Mike Matson has reiterated a 'Buy' rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a price target of $96.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:48 am

PHM

BTIG analyst Carl Reichardt maintains a Buy rating on PulteGroup (NYSE:PHM) and raises the price target from $83 to $100.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 9:47 am